Duloxetine in the treatment of postpartum-onset and non-postpartum onset major depressive disorder.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2016
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder; Postnatal depression
- Focus Therapeutic Use
- Acronyms DuloxPPD
- 09 Feb 2016 Status changed from completed to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Aug 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.